Lonza Group Ag Long-Term Investments 2012-2024 | LZAGY
Lonza Group Ag long-term investments from 2012 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Lonza Group Ag long-term investments for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
- Lonza Group Ag long-term investments for 2023 were $0B, a 0% decline from 2022.
- Lonza Group Ag long-term investments for 2022 were $0B, a 0% decline from 2021.
- Lonza Group Ag long-term investments for 2021 were $0B, a 0% decline from 2020.
| Lonza Group Ag Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2017 | $0 |
| 2016 | $31 |
| 2015 | $0 |
| 2014 | $26 |
| 2013 | $21 |
| 2012 | $22 |
| 2011 | $23 |
| Lonza Group Ag Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | $15 |
| 2017-06-30 | $1 |
| 2016-12-31 | $32 |
| 2016-06-30 | $1 |
| 2015-12-31 | $1 |
| 2015-06-30 | $1 |
| 2014-12-31 | $26 |
| 2014-06-30 | |
| 2013-12-31 | $21 |
| 2013-06-30 | |
| 2012-12-31 | $22 |
| 2012-06-30 | |
| 2011-12-31 | $23 |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $52.624B | $7.468B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||